Discordance between preclinical and clinical testing of NaV1.7-selective inhibitors for pain. Yang J, Xie YF, Smith R, Ratte S, et al. Pain 2024 Oct 23. doi: 10.1097/j.pain.0000000000003425.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang J, Xie YF, Smith R, Ratte S, et al. Discordance between preclinical and clinical testing of NaV1.7-selective inhibitors for pain. Pain 2024 Oct 23. doi: 10.1097/j.pain.0000000000003425.
PMID: 39446737